ArisGlobal Reports Strong Q1 2026 Momentum with Accelerating Enterprise AI Transformation Â
Expanding NavaX adoption, new Top Pharma wins, and continued global ...
ArisGlobal Expands NavaX Agents Suite with Three New AI Agents to Orchestrate Intelligence Across Life Sciences Operations
New Distribution, Signals, and Intelligence Agents reduce manual effort, streamline compliance tasks, and orchestrate end-to-end decision workflows.
ArisGlobal Launches ReporterX to Accelerate AI-Driven Collection of Patient Data from the Field
New NavaX-powered capabilities combine Dynamic Data Extraction, Translation, Conversational AI, and Intelligent Follow-up Management to modernize adverse event, medical information and product quality complaints reporting.
ArisGlobal Launches NavaX Translation to Eliminate Manual Translation in Global Pharmacovigilance
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
ArisGlobal Launches XDI
XDI brings the first federated solution for life sciences, collapsing data silos, unifying meaning, and ...
ArisGlobal Announces XDI, Three New Agents, and NavaX Translation
MADRID, SPAIN – February 11, 2026 – ArisGlobal, an AI-first technology company at ...
YURiA-PHARM Adopts LifeSphere® Regulatory
The Ukrainian pharmaceutical company modernizes regulatory operations with a centralized platform and multi-phase innovation strategy.
Global Biopharmaceutical Company Goes Live with LifeSphere® NavaX in Japan
The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
ArisGlobal Accelerates Growth and AI Adoption Following Strong 2025 Performance
More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum
ArisGlobal Announces Breakthrough 2026 Speaker LineupÂ
More than 50 executive speakers and 300 life sciences professionals ...
